MaxCyte invites you to join our webinar in collaboration with Cell & Gene Therapy Insights on the development of non-viral gene delivery platforms for CAR-T manufacturing, on Wednesday, July 24, 2024 at 11:00 am EDT. Register now to gain a deeper understanding of different non-viral processes for CAR-T manufacturing. Explore cutting-edge approaches to CAR expression via knock-ins mediated by homology-directed repair (HDR) or homology-independent targeted insertion (HITI). Learn how to achieve high cell engineering efficiencies, cell viability and scalability, and more. We look forward to connecting with you! #Cas9 #CRISPR https://bit.ly/3y4VA4U
MaxCyte, Inc.’s Post
More Relevant Posts
-
Join our webinar next week to learn about development of a #nonviral CAR-T manufacturing process. #celltherap #cellengineering #CRISPR
MaxCyte invites you to join our webinar in collaboration with Cell & Gene Therapy Insights on the development of non-viral gene delivery platforms for CAR-T manufacturing, on Wednesday, July 24, 2024 at 11:00 am EDT. Register now to gain a deeper understanding of different non-viral processes for CAR-T manufacturing. Explore cutting-edge approaches to CAR expression via knock-ins mediated by homology-directed repair (HDR) or homology-independent targeted insertion (HITI). Learn how to achieve high cell engineering efficiencies, cell viability and scalability, and more. We look forward to connecting with you! #Cas9 #CRISPR https://bit.ly/3y4VA4U
-
-
Discover how decentralized manufacturing is reshaping the landscape of cell and gene therapy development in this blog capturing insights from our Bridging the Gap webinar series. Gain valuable insights from experts like Dorothea Ledergerber, PhD, Chief Technical Officer at Tigen Pharma, and Patrick Hanley, PhD, Director of the Cellular Therapy Program at Children’s National Hospital. Read the full blog and register for future webinars here: https://hubs.ly/Q02xHWy70 #CellTherapy #GeneTherapy #Innovation #WebinarSeries
-
-
A creative mind, seeking my next adventure! | Gene therapy | Preclinical testing | Protein engineering and production | Project Leadership and Management
FDA has released a draft guidance titled “Platform Technology Designation Program for Drug Development” (https://lnkd.in/dSyWGUY4), aimed at accelerating future drug applications for subsequent treatments derived from the same platform technology. A platform technology is defined as a well-understood and reproducible technology, which may include a nucleic acid sequence, molecular structure, mechanism of action, delivery method, vector, or a combination of these technologies. This can ease gene therapy regulatory burden and speed up next generation therapies. #FDA #GeneTherapy #Regulation #Guidance https://lnkd.in/d57D_r73
-
-
It was a pleasure to sit down with Fierce Biotech to share my thoughts on the state of the cell and gene industry and the pivotal role that the cold chain is playing in it's progression. Watch the video below: #cellandgene #SupplyChainSolutions #ColdChain #TemperatureControl #PharmaSupplyChain #Logistics #Sustainability #Cryo
How are current innovations shaping the future of cell and gene therapies and cold chain logistics? "This interview explores the increasing demand for real-time visibility technologies and high-performance shipping solutions. Emilio Frattaruolo, CPPL, VP of Cell and Gene Therapies, highlights the importance of thinking holistically about supply chains, from early-stage research through to commercialization and scaling up for larger patient populations." Watch it now! ➡️ https://hubs.li/Q02HP7Fl0 #CellAndGeneTherapies #ColdChainLogistics #PharmaSupplyChain Fierce Biotech
-
-
Alex Templar, Senior Business Development Manager at the Cell and Gene Therapy Catapult, talking at Informa Connect's Cell and Gene Therapy #Manufacturing and #Commercialisation Europe event in #Dublin today! We gave two talks today delving into how you can #accelerate your in-house GMP manufacturing capabilities, and how you can use #ProcessAnalyticalTechnologies to develop closed, automated and adaptable processes. Learn more about how we can support your #ATMP manufacturing development: https://buff.ly/3FdtV1S #CellTherapies #GeneTherapies #AdvancedTherapies
-
-
Insightful perspective from one of the industries leading experts in this field.
How are current innovations shaping the future of cell and gene therapies and cold chain logistics? "This interview explores the increasing demand for real-time visibility technologies and high-performance shipping solutions. Emilio Frattaruolo, CPPL, VP of Cell and Gene Therapies, highlights the importance of thinking holistically about supply chains, from early-stage research through to commercialization and scaling up for larger patient populations." Watch it now! ➡️ https://hubs.li/Q02HP7Fl0 #CellAndGeneTherapies #ColdChainLogistics #PharmaSupplyChain Fierce Biotech
-
-
BD | Best-in-Class mRNA and Viral Vectors | Dad | Husband | Best-in-Class Burgers and Pancakes
Going to #ISCT next week? Meet up with my associate Manuel Valdés, PhD to learn how Exothera can help with your RNA and Viral Vector projects!
Are you in Vancouver for the International Society for Cell & Gene Therapy Annual Meeting next week? Do you want to know more about Exothera's solutions and services for cell and gene therapy manufacturing? Our BD, Manuel Valdés, PhD, will be there to meet you! Do not hesitate to contact us if you want to organize a face-to-face meeting with him. Engage with experts and discover how to overcome obstacles and pave your way to clinical and commercial success! #exothera #ISCT24 #celltherapymanufacturing
-
-
In a new blog post, we highlight Sexton Biotechnologies cell performance media and fill & packaging tools that can simplify your downstream cell and gene therapy processes. Sean Werner, Chief Technology Officer of Cell Processing, also offers insights on moving the CGT industry forward. Read on to learn more and download an interview with Sean. #formulation #autologous #fillandfinish #celltherapy #CGT https://lnkd.in/gHrfuxZ6
-
-
Interesting article regarding the future of cell and gene therapies and the cold chain logistics they require. Our VP of Cell and Gene Therapies Emilio Frattaruolo, CPPL is always happy to discuss your specific requirements!
How are current innovations shaping the future of cell and gene therapies and cold chain logistics? "This interview explores the increasing demand for real-time visibility technologies and high-performance shipping solutions. Emilio Frattaruolo, CPPL, VP of Cell and Gene Therapies, highlights the importance of thinking holistically about supply chains, from early-stage research through to commercialization and scaling up for larger patient populations." Watch it now! ➡️ https://hubs.li/Q02HP7Fl0 #CellAndGeneTherapies #ColdChainLogistics #PharmaSupplyChain Fierce Biotech
-
-
Come join Senthil Ramaswamy and I as we discuss the critical needs for the future of Cell and Gene Therapies
Join us on June 13 for an insightful webinar on the revolutionary innovations that are shaping the cell and gene therapy manufacturing space. In this webinar, we will explore the complex landscape of process development and analytical development, while reviewing key focus areas based on lessons learned across our experiences. The discussion will be framed around where the market is headed and how breakthroughs will make for a bright future. Register today on https://lnkd.in/gKutKXGY Date: Thursday, June 13, 2024 Time: 11am EDT | 5pm CET Speaker: Mark Santos, Global Head of Commercial Development and Strategic Marketing, Cell & Gene Technologies #celltherapy #genetherapy #LonzaCGT #RealizingPotentialTogether
-
